Travere Therapeutics, Inc. (NASDAQ:TVTX) Q1 2026 Earnings Call Transcript

Travere Therapeutics, Inc. (NASDAQ:TVTX) Q1 2026 Earnings Call Transcript May 4, 2026

Travere Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.4 EPS, expectations were $-0.24203.

Operator: Hello, and welcome to Travere Therapeutics, Inc.’s first quarter 2026 financial results conference call. Today’s call is being recorded. At this time, I would like to turn the conference call over to Nivi Nehra, Vice President, Corporate Communications and Investor Relations....